Shrydus Industries Ltd
₹ 3.60
5.57%
29 May
- close price
About
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
Key Points
- Market Cap ₹ 11.5 Cr.
- Current Price ₹ 3.60
- High / Low ₹ 6.48 / 2.55
- Stock P/E
- Book Value ₹ 13.3
- Dividend Yield 0.00 %
- ROCE -0.12 %
- ROE -0.12 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.27 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -39.6% over past five years.
- Promoter holding is low: 25.9%
- Company has a low return on equity of 1.69% over last 3 years.
- Company has high debtors of 6,734 days.
- Promoter holding has decreased over last 3 years: -10.8%
- Working capital days have increased from 6,712 days to 19,053 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.01 | 0.44 | 0.27 | 0.23 | 0.00 | 5.20 | 2.48 | 9.00 | 9.29 | 9.45 | 4.51 | 0.20 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| 1.34 | 0.59 | 0.38 | 0.24 | 2.45 | 5.25 | 2.75 | 8.94 | 9.02 | 8.93 | 3.76 | 0.26 | |
| Financing Profit | -1.33 | -0.15 | -0.11 | -0.01 | -2.45 | -0.05 | -0.27 | 0.06 | 0.27 | 0.52 | 0.74 | -0.06 |
| Financing Margin % | -13,300.00% | -34.09% | -40.74% | -4.35% | -0.96% | -10.89% | 0.67% | 2.91% | 5.50% | 16.41% | -30.00% | |
| 1.35 | -0.01 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 | |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.02 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.06 | 0.29 | 0.52 | 0.74 | -0.05 |
| Tax % | -450.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | -3.45% | 0.00% | 0.00% | 0.00% |
| 0.11 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.04 | 0.30 | 0.52 | 0.73 | -0.05 | |
| EPS in Rs | 0.05 | -0.07 | -0.05 | -0.00 | -0.99 | -0.02 | -0.11 | 0.02 | 0.12 | 0.16 | 0.23 | -0.02 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -40% |
| 3 Years: | -72% |
| TTM: | -96% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 13% |
| 3 Years: | % |
| TTM: | -107% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 19% |
| 3 Years: | -49% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 0% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.66 | 12.01 | 32.02 | 32.02 |
| Reserves | -5.41 | -5.58 | -5.68 | -5.69 | -8.08 | -8.12 | -8.39 | -8.35 | -7.75 | -6.05 | 10.70 | 10.64 |
| Borrowing | 0.01 | 0.35 | 0.01 | 0.06 | 0.00 | 0.02 | 0.24 | 1.72 | 1.86 | 10.91 | 0.02 | 0.01 |
| 0.51 | 0.55 | 0.52 | 0.53 | 0.02 | 5.15 | 2.57 | 2.27 | 3.14 | 0.02 | 0.02 | 0.04 | |
| Total Liabilities | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 | 42.71 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| 4.08 | 4.30 | 3.83 | 3.88 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.74 | 42.69 | |
| Total Assets | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 | 42.71 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.49 | 0.25 | 0.07 | 0.04 | -0.40 | 0.13 | -0.31 | -1.51 | -0.15 | -13.46 | -25.14 | 0.11 | |
| 4.17 | -0.40 | -0.29 | -0.09 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
| -0.32 | 0.35 | -0.34 | 0.05 | -0.55 | 0.02 | 0.22 | 1.48 | 1.04 | 12.58 | 25.13 | 0.00 | |
| Net Cash Flow | 0.35 | 0.20 | -0.56 | 0.00 | -0.03 | 0.15 | -0.09 | -0.03 | 0.88 | -0.88 | -0.03 | 0.11 |
| Free Cash Flow | -2.08 | 0.25 | 0.07 | 0.04 | -0.40 | 0.13 | -0.31 | -1.51 | -0.15 | -13.46 | -25.15 | 0.11 |
| CFO/OP | 262% | -167% | -64% | -400% | 16% | -260% | 115% | -2,517% | -56% | -2,588% | -3,352% | -183% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE % | -33.94% | -4.21% | -3.21% | -0.30% | -112.18% | -5.21% | -33.54% | 5.80% | 22.90% | 13.21% | 3.00% | -0.12% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number |
|
||||||||
| Current Ratio Ratio |
|||||||||
| Debt-Equity Ratio Ratio |
|||||||||
| Trade Receivables Turnover Ratio Ratio |
|||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - Shrydus Industries files FY26 Secretarial Compliance Report; notes penalties of ₹11,800, ₹1,23,900 and ₹88,500.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
25 May - Newspaper Publication for Audited financial result for the quarter and year ended March 31, 2026
- Audited Standalone And Consolidated Financial Result For The Quarter And Year Ended March 31, 2026 22 May
-
Board Meeting Outcome for Outcome Of The Board Meeting
22 May - Board approved audited standalone and consolidated results for quarter and year ended March 31, 2026.
-
Board Meeting Intimation for Consider And Approve The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026;
15 May - Board meeting on 22 May 2026 to approve audited standalone and consolidated FY2026 results.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector